Metraipolis › archive › dc_2e9ebfedc1c3

Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana — Europe PMC PMID:34543293

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34543293
DOI
10.1371/journal.pntd.0009744
License (as archived)
CC0-1.0
Archived
2026-11-02T18:29:40.969Z
SHA-256 of the archived text
349f3589f6b3bd5ede8a73aa44cfb9d289b19ab6d7696a790a210169f51994b0
Stable URL of this page
https://metraipolis.com/documento/dc_2e9ebfedc1c3

How to cite

Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana — Europe PMC PMID:34543293 — Europe PMC (en), https://europepmc.org/article/MED/34543293 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2e9ebfedc1c3 (Metraipolis archive dc_2e9ebfedc1c3, sha256 349f3589f6b3bd5ede8a73aa44cfb9d289b19ab6d7696a790a210169f51994b0)
BibTeX
@misc{dc2e9ebfedc1c3,
  title = {Surveillance for peri-elimination trachoma recrudescence: Exploratory studies in Ghana — Europe PMC PMID:34543293},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34543293},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2e9ebfedc1c3; sha256 349f3589f6b3bd5ede8a73aa44cfb9d289b19ab6d7696a790a210169f51994b0},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34543293. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Introduction: To date, eleven countries have been validated as having eliminated trachoma as a public health problem, including Ghana in 2018. Surveillance for recrudescence is needed both pre- and post-validation but evidence-based guidance on appropriate strategies is lacking. We explored two potential surveillance strategies in Ghana. Methodology/principal findings: Amongst randomly-selected communities enrolled in pre-validation on-going surveillance between 2011 and 2015, eight were identified as having had trachomatous-inflammation follicular (TF) prevalence ≥5% in children aged 1-9 years between 2012 and 2014. These eight were re-visited in 2015 and 2016 and neighbouring communities were also added ("TF trigger" investigations). Resident children aged 1-9 years were then examined for trachoma and had a conjunctival swab to test for Chlamydia trachomatis (Ct) and a dried blood spot (DBS) taken to test for anti-Pgp3 antibodies. These investigations identified at least one community with evidence of probable recent Ct ocular transmission. However, the approach likely lacks sufficient spatio-temporal power to be reliable. A post-validation surveillance strategy was also evaluated, this reviewed the ocular Ct infection and anti-Pgp3 seroprevalence data from the TF trigger investigations and from the pre-validation surveillance surveys in 2015 and 2016. Three communities identified as having ocular Ct infection >0% and anti-Pgp3 seroprevalence ≥15.0% were identified, and along with three linked communities, were followed-up as part of the surveillance strategy. An additional three communities with a seroprevalence ≥25.0% but no Ct infection were also followed up ("antibody and infection trigger" investigations). DBS were taken from all residents aged ≥1 year and ocular swabs from all children aged 1-9 years. There was evidence of transmission in the group of communities visited in one district (Zabzugu-Tatale). There was no or little evidence of continued transmission in other districts, suggesting previous infection identified was transient or potentially not true ocular Ct infection. Conclusions/significance: There is evidence of heterogeneity in Ct transmission dynamics in northern Ghana, even 10 years after wide-scale MDA has stopped. There is added value in monitoring Ct infection and anti-Ct antibodies, using these indicators to interrogate past or present surveillance strategies. This can result in a deeper understanding of transmission dynamics and inform new post-validation surveillance strategies. Opportunities should be explored for integrating PCR and serological-based markers into surveys conducted in trachoma elimination settings.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2021 (prima pubblicazione 2021-09-20).
Identificativi: PMID 34543293 · PMCID PMC8519445 · DOI 10.1371/journal.pntd.0009744.
Descrittori MeSH principali: Population Surveillance; Epidemiological Monitoring.
Pagina: https://europepmc.org/article/MED/34543293 — https://doi.org/10.1371/journal.pntd.0009744. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-02T18:22:08.103Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.